secwatch.observer — SEC 8-K summary
======================================

Issuer:     Notable Labs, Ltd. (—)
CIK:        0001603207
Form:       8-K
Filed at:   2024-09-16T23:59:59+00:00
Accession:  0001493152-24-036378
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Notable Labs appoints Kaile Zagger as Interim CEO and Chief Restructuring Officer
--------------------------------------------------------------------------------

- Kaile Zagger appointed Interim CEO and CRO, effective September 16, 2024.
- Dr. Joseph Wagner steps down as interim CEO but remains Chief Scientific Officer.
- Zagger is Managing Director at Province, LLC; services provided at $900/hour.
- Zagger has over 20 years healthcare experience, including distressed turnarounds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1603207/000149315224036378/0001493152-24-036378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1603207/000149315224036378/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-036378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer